These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 30191868)

  • 1. Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.
    McDowell LJ; Rock K; Xu W; Chan B; Waldron J; Lu L; Ezzat S; Pothier D; Bernstein LJ; So N; Huang SH; Giuliani M; Hope A; O'Sullivan B; Bratman SV; Cho J; Kim J; Jang R; Bayley A; Ringash J
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):340-352. PubMed ID: 30191868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
    Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
    Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prevalence and Determinants of Return to Work in Nasopharyngeal Carcinoma Survivors.
    So N; McDowell LJ; Lu L; Xu W; Rock K; Waldron J; Bernstein LJ; Chan HB; Huang SH; Giuliani M; Hope A; O'Sullivan B; Bratman SV; Cho J; Kim J; Jang R; Bayley A; Ringash J
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):134-145. PubMed ID: 31568813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late toxicity, evolving radiotherapy techniques, and quality of life in nasopharyngeal carcinoma.
    Lastrucci L; Bertocci S; Bini V; Borghesi S; De Majo R; Rampini A; Pernici P; Gennari PG
    Radiol Med; 2017 Apr; 122(4):303-308. PubMed ID: 28070838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques.
    Fang FM; Tsai WL; Chen HC; Hsu HC; Hsiung CY; Chien CY; Ko SF
    Cancer; 2007 Jan; 109(2):313-21. PubMed ID: 17154159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy.
    Chen AM; Daly ME; Farwell DG; Vazquez E; Courquin J; Lau DH; Purdy JA
    JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):129-33. PubMed ID: 24337483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Intensity-Modulated Radiation Therapy on the Life Quality of Patients with Nasopharyngeal Carcinoma.
    Chen J; Liu P; Wang Q; Wu L; Zhang X
    Cell Biochem Biophys; 2015 Dec; 73(3):731-6. PubMed ID: 27259317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
    Zheng Y; Han F; Xiao W; Xiang Y; Lu L; Deng X; Cui N; Zhao C
    Radiat Oncol; 2015 Jan; 10():17. PubMed ID: 25582731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy.
    Huang TL; Tsai MH; Chuang HC; Chien CY; Lin YT; Tsai WL; Fang FM
    Radiat Oncol; 2020 Apr; 15(1):84. PubMed ID: 32307024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of long-term quality of life and their predictors in survivors between paediatric and adult nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
    Jin J; Guo SS; Liu LT; Wen DX; Liu RP; Lin JY; Liu SQ; Sun XS; Liang YJ; Tang LQ; Mai HQ; Chen QY
    BMC Cancer; 2024 Oct; 24(1):1223. PubMed ID: 39358733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial.
    Xiang L; Rong JF; Xin-Chen ; Li XY; Zheng Y; Ren PR; Lin S; Wen QL; He LJ; Zhang JW; Shang CL; Yang HR; Fan J; Pang HW; Zhang J; Tan BX; Zhang L; Du XB; Wen SM; Jiang L; Qin G; Wu JB
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(4):914-924. PubMed ID: 37356553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy.
    McDowell LJ; Ringash J; Xu W; Chan B; Lu L; Waldron J; Rock K; So N; Huang SH; Giuliani M; Hope A; O'Sullivan B; Bratman SV; Cho J; Kim J; Jang R; Bayley A; Bernstein LJ
    Radiother Oncol; 2019 Feb; 131():179-185. PubMed ID: 30279047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnaires.
    Bian X; Song T; Wu S
    Expert Rev Anticancer Ther; 2015 Jan; 15(1):109-19. PubMed ID: 25231774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Zhu W; Chen F; Li J; Wang W; Zhang H; Yang G; Zou L; Zhu Y; Yuan W; Ding H; Song X; Wang S
    Acta Otolaryngol; 2019 Mar; 139(3):263-268. PubMed ID: 30870056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.
    Yang H; Hu W; Wang W; Chen P; Ding W; Luo W
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e47-54. PubMed ID: 23122981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma.
    Sommat K; Ong WS; Hussain A; Soong YL; Tan T; Wee J; Fong KW
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):574-580. PubMed ID: 28581397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiotherapy provides better quality of life than two-dimensional conventional radiotherapy for patients with stage II nasopharyngeal carcinoma.
    Pan XB; Huang ST; Chen KH; Jiang YM; Ma JL; Qu S; Li L; Chen L; Zhu XD
    Oncotarget; 2017 Jul; 8(28):46211-46218. PubMed ID: 28515352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Survivals, Toxicities and the Role of Chemotherapy in Early-Stage Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy: A Retrospective Study with 15-Year Follow-up.
    Wang L; Miao J; Huang H; Chen B; Xiao X; Zhu M; Liang Y; Xiao W; Huang S; Peng Y; Deng X; Lv X; Xia W; Xiang Y; Guo X; Han F; Zhao C
    Cancer Res Treat; 2022 Jan; 54(1):118-129. PubMed ID: 34098625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep characteristics and psychological symptoms in patients with locally advanced nasopharyngeal carcinoma before and after intensity-modulated radiotherapy and concurrent chemotherapy.
    Qin L; Mo YL; Li L; Wei ZJ; Zhu XD; Yin X; Wei Q
    Psychol Health Med; 2015; 20(6):662-9. PubMed ID: 25299689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in patients with nasopharyngeal carcinoma receiving IMRT vs IMPT: a multicenter prospective longitudinal study.
    Chung CF; Huang BS; Wang YM; Huang YT; Chen SC
    Support Care Cancer; 2024 Mar; 32(3):203. PubMed ID: 38430411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.